Zum Hauptinhalt springen
User account menu
Einloggen
Reset password
Suche
Secondary navigation
About Us
Community Outreach
News
Main Navigation
Network
Forschung
Menschen
Meetings
Ressourcen
Breadcrumb
News
All News Releases
All News Releases
Back to top
Phase III Trial of Dapivirine Ring Begins in Africa: ASPIRE testing new HIV prevention approach for women
July 24, 2012
Reduced Glycerin Formulation of Tenofovir Vaginal Gel Safe for Rectal Use
May 17, 2012
New findings reported by Microbicide Trials Network at International HIV Prevention Meeting
April 17, 2012
Rectal Formulation of Tenofovir Gel Found Safe and Acceptable in Early Phase Clinical Study
March 5, 2012
MTN Statement on Decision to Discontinue Use of Tenofovir Gel in VOICE, a Major HIV Prevention Study in Women
November 25, 2011
First Combination ARV Vaginal Ring for HIV Prevention Being Tested in Phase I Safety Trial
November 15, 2011
MTN Statement on Decision to Discontinue Use of Oral Tenofovir Tablets in VOICE, a Major HIV Prevention Study in Women
September 28, 2011
VOICE Study will Continue as it Considers What Action to Take After Results of Two Trials
July 13, 2011
Researchers Take Another Step Closer to HIV Prevention Product for Use During Pregnancy
June 20, 2011
HIV Prevention Trial Milestone: VOICE Study Completes Enrollment of 5,000 Women
June 6, 2011
Pagination
First page
« First
Previous page
‹ Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Current page
6
Page
7
Page
8
Next page
Next ›
Last page
Last »